PathWest transitions to updated AS/NZS 4308:2023 standard

PathWest transitions to updated AS/NZS 4308:2023 standard

PathWest has now fully transitioned to the updated Australian Standard AS/NZS 4308:2023 – Procedures for specimen collection, testing and the quantification of drugs in urine.

The new standard introduces revised cut-off thresholds for several drug classes and updated reporting formats for amphetamine-type substances and benzodiazepines to enhance clarity and compliance.

For full details on the changes and updated thresholds, visit the Frequently Asked Questions section on the PathWest website or contact the PathWest Toxicology team at toxi@health.wa.gov.au or (08) 6383 4121.